Improving cancer screening and prevention in diverse populations
Official title: HFH-MSU CSRN ACCrual Enrollment and Screening Site
Funded at Henry Ford Health + Michigan State University Health Sciences · NIH-11035148 · Data updated 2026-11-12
This study is working to improve cancer screening and prevention by teaming up with local health experts to find and support people at risk, especially in diverse communities, so they can get the care they need early on.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Henry Ford Health + Michigan State University Health Sciences NIH-funded |
| Lab location | 1 site (East Lansing, United States) |
| Project start | February 1, 2024 |
| Project end | December 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $876,366 |
| NIH project number | 5UG1CA287007-02 |
| Project ID | NIH-11035148 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals from racially and socioeconomically diverse backgrounds who are at risk for advanced cancers.
✕Less likely to help
Patients who are not at risk for cancer or who do not belong to the targeted demographic groups may not receive benefits from this research.
What this research studies
This research focuses on enhancing cancer screening and prevention efforts through a collaborative approach between Henry Ford Health and Michigan State University. It aims to identify and engage at-risk populations using electronic health records, ensuring effective recruitment and long-term follow-up for participants. The project builds on over 20 years of experience in conducting multi-site cancer trials, with a particular emphasis on serving racially and socioeconomically diverse communities. By leveraging past successes in major cancer screening trials, this initiative seeks to improve early detection and treatment outcomes for various cancers.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer detection rates and better health outcomes for patients in underserved communities.
How similar studies have gone: Previous research has shown success in similar cancer screening approaches, particularly in diverse populations, indicating a strong potential for impactful outcomes.
Where this research is happening
-
Henry Ford Health + Michigan State University Health Sciences
East Lansing, United States Active
Researchers
- Principal investigator: Neslund-Dudas, Christine Marie — Henry Ford Health + Michigan State University Health Sciences
- Study coordinator: Neslund-Dudas, Christine Marie
Related research
Other NIH-funded projects on the same topics.
-
Keloid recurrence study using multi-omics in diverse patients
A research effort will look at why keloids come back after surgery, especially in African American patients, using comprehensive molecular data from patient samples.
-
A national program to build a precise, personalized health data platform for all of us participants
This grant supports expanding and improving a national health data platform to help tailor care to each person using their genetic, health, and lifestyle information.
-
Computational modeling of female hormone balance and drug responses
A new computational model uses patient-like data to predict how metabolic drugs will work in women across their hormonal cycles and different reproductive stages.
-
Anti-CD38 immunotherapy for severe hidradenitis suppurativa
A new treatment using anti-CD38 therapy is being tested for people with severe hidradenitis suppurativa who have not responded to prior therapies.
-
Vitamin D, gut bacteria and dementia risk in older adults with HIV
This work will look at whether low vitamin D and changes in gut bacteria are linked to higher dementia risk in older adults living with chronic HIV and similar community members.
-
Screening new compounds to reverse gene signatures in IPF lungs
A researcher hopes to find compounds that reverse harmful gene changes in the lungs of people with idiopathic pulmonary fibrosis (IPF).
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.